The change follows rising complaints about pharmacies refusing to cut tablet strips, forcing patients to buy extra medication. NEW DELHI: Patients may no longer be forced to buy an entire strip of ...

Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...

Much to the relief of the needle-shy, the Food and Drug Administration has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, ...

We may receive a commission on purchases made from links. With the iPad, Apple has one of the most sought-after tablet lineups on the market, though in typical Apple fashion, a purchase can run much ...

Metformin has a strong claim to being one of the most influential medicines of the past century. For decades, it has ...

April 23 (Reuters) - Novo Nordisk's oral GLP-1 drug significantly lowered blood sugar levels in children and adolescents with ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. SEE ALSO: Live updates on ...

The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections. By Dani Blum and Rebecca Robbins The Food and Drug Administration on Wednesday approved a ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

GLP-1 medications that suppress appetite are allowing people to better manage diabetes and obesity. As weight-loss drug ...

Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...